Neogen Corporation (NEOG) and Utah Medical Products (UTMD) Head to Head Survey

Neogen Corporation (NASDAQ: NEOG) and Utah Medical Products (NASDAQ:UTMD) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.


Utah Medical Products pays an annual dividend of $1.06 per share and has a dividend yield of 1.4%. Neogen Corporation does not pay a dividend. Utah Medical Products pays out 30.4% of its earnings in the form of a dividend.

Insider and Institutional Ownership

86.1% of Neogen Corporation shares are held by institutional investors. Comparatively, 66.8% of Utah Medical Products shares are held by institutional investors. 4.2% of Neogen Corporation shares are held by insiders. Comparatively, 9.1% of Utah Medical Products shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Neogen Corporation and Utah Medical Products’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Neogen Corporation $373.21 million 8.04 $81.51 million $1.19 65.94
Utah Medical Products $39.60 million 7.18 $20.09 million $3.49 21.91

Neogen Corporation has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than Neogen Corporation, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Neogen Corporation and Utah Medical Products, as reported by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neogen Corporation 0 1 0 0 2.00
Utah Medical Products 0 0 0 0 N/A


This table compares Neogen Corporation and Utah Medical Products’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Neogen Corporation 12.28% 9.93% 8.85%
Utah Medical Products 32.98% 17.91% 15.95%

Volatility & Risk

Neogen Corporation has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500.


Neogen Corporation beats Utah Medical Products on 7 of the 13 factors compared between the two stocks.

Neogen Corporation Company Profile

Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the production and marketing of products dedicated to animal health, including a range of consumable products marketed to veterinarians and animal health product distributors. The Animal Safety segment also provides genetic identification services. Additionally, the Animal Safety segment produces and markets rodenticides, disinfectants and insecticides to assist in the control of rodents and disease in and around agricultural, food production and other facilities.

Utah Medical Products Company Profile

Utah Medical Products, Inc. (UTMD) is engaged in the business of producing medical devices that are disposable and for hospital use. The Company’s product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME, PATHFINDER PLUS, HOLMIUM LASER FIBRES, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN, and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. UTMD markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit, the labor and delivery department and the women’s health center in hospitals, as well as products sold to outpatient clinics and physician’s offices.

What are top analysts saying about Neogen Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Neogen Corporation and related companies.


Leave a Reply

share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit